Discussion
Down syndrome (DS), the most frequent birth defect (about 1 in 700 births) arises from trisomy of chromosome 21. Molecular analysis of very rare cases of partial trisomy 21 identi®ed a critical region (DCR1) on sub-band 21q22.2, duplication of which is associated with many features of the syndrome, including skeletal abnormalities, hypotonia and mental retardation (Rahmani et al., 1989; Delabar et al., 1993) . Cloning and characterization of genes from DCR1 may provide insights into their potential roles in DS.
We and others have recently identi®ed and characterized a new human gene, tprd, localized in the DCR region (Tsukahara et al., 1996; Dahmane et al., 1998) . TPRD contains, in its N-terminal region, three units of a 34-amino acid repeat similar to the tetratricopeptide (TPR) motif (Sikorski et al., 1990) . Although the physiological function of TPRD has not been determined, the TPR motifs are found in proteins involved in the regulation of RNA synthesis or mitosis (Nicolet and Craig, 1989; Hirano et al., 1990; Honore Â et al., 1992; Chen et al., 1994; Lamb et al., 1995; Blatch et al., 1997) and appear to be involved in protein-protein interactions (Das et al., 1998) .
To investigate tprd function and its role in DS pathogenesis, the preliminary step is the analysis of its expression pattern during development.
Human tprd cDNAs, that we have recently isolated by cDNA selection (Dahmane et al., 1998) , were used to screen a mouse liver lgt11 cDNA library (Clontech). Isolated clone inserts were ampli®ed by PCR, subcloned in plasmid vector and sequenced. These cDNAs present a strong similarity to the human tprd and are fully homologous to the sequence of mtprd recently reported (Tsukahara et al., 1998) . One of our clones containing part of the ORF downstream to the TPR motifs (nt 2847±3545 of accession number AB008516), was used to generate the antisense and the sense probes to study mtprd expression. These probes are located downstream of the region subject to variations in the isoforms proposed by Tsukahara et al. (1998) .
In the earlier stages, E8.5±E9.5, hybridization of the mtprd probe revealed the uniform presence of the transcripts in the embryonic tissues (Fig. 1A) . The signal was weaker in extra-embryonic structures.
In E10±E11.5 mouse embryos, mtprd was expressed in all tissues, but the signal showed tissue speci®c intensity (Fig.  1C,E) with the highest expression in the nervous system. Two expression levels were observed among the nervous structures. The strongest signal was found in the mantle zone and the intermediate zone along the neural tube, including the telencephalon, the mesencephalon, the metencephalon, the spinal cord, and in the root ganglia. A relatively weaker level of expression was displayed by the ventricular zone of the neural tube, the optic stalk and the olfactory epithelium. In non-nervous tissues, a higher mtprd expression, similar to ventricular zone expression level, was observed in the branchial arches, in the lung and stomach primordia, and in the vertebral centri. In all the other structures, including the heart and the liver primordia, a very low signal was observed, which was nonetheless higher than the background displayed by the negative control (Fig. 1D) . In later stages of mouse development E11.5±E15, mtprd expression persisted at a high level in the nervous system (Fig. 1F±N ). This very strong signal was displayed in most nervous structures, including the intermediate zone in developing brain and spinal cord, in cranial and root ganglia, in Fig. 2 . mtprd expression pattern in adult mouse brain. Note the absence of silver label in the negative control hybridization (B). CA, pyramidal cell layer of hippocampus; Ce, cerebellum; cp, caudate nucleus-putamen; Cx, cerebral cortex; dcn, deep cerebellar nuclei; dg, dentate gyrus; gcl, granular cell layer of cerebellum; gr, granular layer of the olfactory bulb; gb, geniculate body; gl, glomerular layer; mc, mitral cell layer; ml, molecular layer of the cerebellum; T, thalamus; I±VI, layers of cerebral cortex. nerves such as intercostal nerves (Fig. 1F ) and in the eye (Fig. 1N) . Relatively weaker expression was found in the retracting ventricular zone of the neural tube, in the corpus striatum, in the cochlea, in the olfactory epithelium and in the primordia of the vibrissa follicles. The strong expression seen in the nervous system persists during development and seems to become more speci®c in later stages, as is seen by, for example, the strong signal of the external layers of the cortex or the neuronal layer in the retina.
In the other body tissues, mtprd was expressed less intensively and in a diversi®ed fashion (Fig. 1G±M) . In the lung, the stomach and the gut the signal persisted throughout development. In the heart and in the liver, the expression level remained very low. A relatively higher expression was seen in the metanephron and later in the de®nitive kidney and in different glandular structures. Expression was also detected at relatively high levels, in skeletal muscles (Fig.  1M ), the diaphragm (Fig. 1H,J) and the tongue. Moreover, a pronounced signal was found in developing bone in the intervertebral disks both in the trunk and in the tail (Fig.  1G±L ), in the ribs (Fig. 1H,K) and con®ned to the perychondrium of all the bones of the developing skeleton (Fig.  1K,M) .
Thus, the mtprd gene showed a developmentally-regulated pattern of expression that evolved during mouse embryogenesis. Although remaining ubiquitous at the gross tissue level (as seen by Northern blot analysis), the pattern becomes tissue-speci®c in terms of intensity during development. The strongest expression was limited to the nervous system and seemed to be restricted to non-proliferating zones which contain differentiated neurons.
This prominent expression of the mtprd gene during nervous system development, led us to study its expression pattern in adult brain.
Though, during embryogenesis, mtprd expression appeared similar in telencephalon, mesencephalon, metencephalon and spinal cord, in adult brain it showed a more restricted expression pattern.
A strong expression of mtprd was found in the cerebral cortex layers II-III and V-VI; layer IV presented no expression and in layer I only a few cells were labeled ( Fig. 2A,C) . In the hippocampus, a prominent expression was observed in the pyramidal cell layer, as well as in the dentate gyrus ( Fig. 2A,D) . A particularly high expression was also found in the olfactory bulb, including the glomerular layer, the mitral cell layer and the granular layer (Fig. 2E) . The cerebellum was also highly marked, at the level of the granular cell layer (Fig. 2F) . Some deep cerebellar nuclei displayed a strong expression. Moreover, a signal was observed in some basal nuclei, particularly in the caudate-putamen and the thalamus ( Fig. 2A,D) . In adult, the strongest expression seemed to be restricted to speci®c cell types as it was seen, for example, in the sub hippocampic region, where large neurons were clearly labelled (Fig. 2D) .
Two main abnormalities have been observed in the brain of DS patients: abnormal lamination patterns (Golden and Hyman, 1994 ) and a lower size of the cerebellum (Raz et al., 1995) . The expression pattern of the mtprd gene showed a high level of transcripts in brain regions corresponding to the abnormal brain regions in DS patients.
Methods
In situ hybridization of mtprd mRNAs has been performed on serial sections of mouse adult brain and embryos using (a-35 S)-UTP labelled riboprobes. All sections were ®xed in 4% (w/v) paraformaldehyde and incubated in proteinase K solution. Slides were hybridized at 528C in a humid chamber and washed with increasing stringency standard saline citrate solutions. The negative controls underwent the same procedure using the sense riboprobe.
